Regulatory Rumblings

SCOTUS, Please Clear Up the Mandatory Ad Disclosure Muddle!

Posted: Feb 27, 2018 12:30pm ET

ANA has filed an amicus curiae, or “friend of the court” brief, with the U.S. Supreme Court in support of CTIA-The Wireless Association’s case against government mandated radiation warnings for cell phones.

READ MORE

ANA Government Relations and Legal Podcast: The Team USA and Liberty Mutual Partnership

Posted: Feb 6, 2018 12:00am ET

In the first-ever ANA Government Relations and Legal Podcast, Chris Sloan, assistance VP and senior corporate counsel at Liberty Mutual, joins host Doug Wood to discuss his brand's partnership with Team USA and a wide array of digital marketing issues.

READ MORE

Navigating Web 3.0: Data Security and Privacy in the Age of GDPR

Posted: Feb 1, 2018 12:00pm ET

This May, companies on both sides of the pond will see what is arguably the largest overhaul of personal data privacy rules in the Internet Era, otherwise known as the General Data Protection Regulation (GDPR).

READ MORE

New Commissioners on the way for the FTC

Posted: Jan 26, 2018 10:45am ET

Yesterday, the White House announced that it has sent the nominations of four new Commissioners for the Federal Trade Commission (FTC) to the Senate for approval.

READ MORE

GDPR Tightens Key Consent and Profiling Rules for Advertisers

Posted: Jan 11, 2018 2:30pm ET

Traps abound for marketers responsible for EU-related activities as the May 2018 EU General Data Protection Regulation (GDPR) compliance deadline approaches. Recent EU guidance about consent for personal data collection and use and guidance on using data for profiling purposes reinforce the belief that EU regulators will be prone to broadly apply GDPR to marketing activities.

READ MORE

New Year, New Legislative Challenges ANA is Ready to Tackle

Posted: Jan 4, 2018 2:00pm ET

As we reflect upon the past year, ANA is very proud to have ended 2017 on a high note with an important victory for the advertising industry, the preservation of advertising deductions in the Tax Cuts and Jobs Act.

READ MORE

Protecting the Tax Deductibility of DTC Advertising

Posted: Dec 12, 2017 3:30pm ET

The U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing today on the cost of prescription drugs, including discussion of a report from the National Academy of Sciences that included a recommendation that Congress “should disallow the tax deductibility of direct-to-consumer advertising of prescription drugs as a business expense.”

READ MORE

Limiting Available Health Info is Bad for America

Posted: Dec 5, 2017 2:30pm ET

Last week, the National Academy of Sciences issued a new report, “Making Medicines Affordable: A National Imperative,” which, among other proposals, recommends that the tax deduction for prescription drug advertising be removed.

READ MORE

It’s not over till it’s over

Posted: Nov 17, 2017 11:30am ET

Yesterday, the House passed its version of the Tax Cuts and Jobs Act – the long-awaited tax reform package that was promised by President Trump. On the Senate side, a somewhat different version of the bill passed through the Finance Committee after several days of debate over amendments.

READ MORE

Pharma Ads Threatened in Senate

Posted: Nov 14, 2017 9:15am ET

Senator Claire McCaskill (D-MO) suddenly and unexpectedly has filed an amendment to the Tax Cuts & Jobs Act released by Chairman Hatch. Her amendment would totally eliminate the advertising costs deduction for pharmaceutical companies.

READ MORE